CClinicalTrials.gg
CompletedNCT03468673SexLifeUpdated Apr 27, 2021

International Validation of a Sexual Quality of Life Questionnaire Specific to HIV and Hepatitis C (PROQOL-SexLife)

An observational study in Sexual Dysfunction, HIV and Hepatitis C, sponsored by University Paris 7 - Denis Diderot. Completed at 17 sites in 4 countries. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-27.

Sponsored by University Paris 7 - Denis Diderot · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
1,164
Ages
18 Years and older
Sex
All
01

Study summary

To develop and validate a specific questionnaire of sexual quality of life in several languages and cultures (France, Brazil, Australia) allowing a meaningful and comprehensive assessment of the sexuality of patients infected with HIV and HCV; Propose reference scoring for sub-populations.

Read the detailed description

Sexual health is a complex construct affecting physical, mental and social well-being. According to studies, sexual disorders are common in people with HIV infection and 25 to 71% of, both men and women regardless of their sexual orientation; and between 39 and 50 % of patients infected with Hepatitis C Virus(HCV). The cause is almost always multifactorial, with psychological, environmental and physiological components, and there may be an iatrogenic effect of treatment. HIV is a chronic disease for people with access to effective treatment. And Hepatitis C while curable is a chronic condition when untreated. In this context, sexuality is an important dimension of quality of life. But the issues are complex and not easily defined. Various studies have highlighted the lack of attention paid to sexuality in a medical management of various chronic conditions such as HIV or cancer. Indeed, a preliminary review of the literature and analysis of the concepts measured by 25 questionnaires on sexuality, shows that these instruments are inadequate to capture all aspects of the sexuality affecting quality of life of people infected with HIV or HCV. If they address physical aspects of sexuality, they address briefly at all socio-psychological and relational sexual life (body image, feeling desirable, self-esteem). Only a limited number of studies focused specifically on the experience of people suffering of sexual dysfunction in HIV and HCV infection. Moreover, these instruments do not assess specific issues related to stigma and problems related to transmission of infections of certain subgroups, particularly in the gay population.

It is an international prospective study (Australia, Brazil, Canada and France) with four phases:

Phase 1. A literature review and interview guide writing.

Phase 2. A qualitative research design based on a grounded theory research perspective:

realization and analysis of interviews with people affected by HIV and HCV, creation of the conceptual framework specific to HIV and HCV.

Phase 3. Questionnaire creation: creation of an item bank; formalization of a pilot questionnaire; forward-backward linguistic validation in each of the target languages (French, Portuguese of Brazil, English), cognitive debriefing and international harmonization; development of the conceptual model of sexual quality of life.

Phase 4. Psychometric validation of the new questionnaire: cross-sectional study by administration of the new questionnaire to 1 400 patients in the 4 countries, along with generic questionnaire about sexuality (Male sexual Health Questionnaire, Female sexual Function Index), the HIV sexual risk questionnaire, and the SF-12v2; Statistic and psychometric analysis; assessment of characteristics of different sub-populations; Propose reference scoring for sub- populations.

Impact of research: the availability of a meaningful and validated tool to detect and assess specifically sexual quality of life in HIV and HCV populations will improve the understanding of specific issues of these sub-populations. The questionnaire is intended for use in research, clinical practice, and during annual visits.

02

Conditions studied

  • Sexual Dysfunction
  • HIV
  • Hepatitis C

Keywords

  • AIDS
  • HCV
  • Questionnaire
  • Qualitative analysis
  • Sexual Quality of Life
  • Psychometric validation
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

People living with HIV and / or HCV and being over the age of 18, and having proficiency in English, French or Portuguese

Inclusion criteria

  • People living with HIV and/or Hepatitis C
  • having proficiency in English, French or Portuguese of Brazil
  • Giving informed consent (oral or written consent according to the legislation of country)

Exclusion criteria

Exclusion Criteria:

  • cognitive impairment or major psychiatric disorders
04

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
1,164 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Psychometric validation of a new questionnaire (PROQOL-SexLife) to assess sexual Quality of Life of people affected by HIV and HCV

    PROQOL-SexLife is the developed questionnaire through qualitative analysis (phase 2 of the study). Because it is specific to these infections, it will be used to assess the sexuality of people affected by HIV and / or Hepatitis C. This questionnaire has the potential to specifically detect sexual dysfunction. It is intended for use in research, clinical practice, and during annual visits.

    Time frame: 4 last weeks

06

Study locations

17 sites
  • University of Sydney
    Sydney, 2006, Australia
  • Center of treatment HIV/Aids - Brazil
    são Paulo, 04121-000, Brazil
  • Clinique m&dicale L'Actuel
    Montréal, Quebec, Canada
  • CHU de Bordeaux
    Bordeaux, 33604, France
  • CHU de Dijon
    Dijon, 21000, France
  • Hôpital de Bicêtre
    Le Kremlin-Bicêtre, 94275, France
  • Hôpital Européen de Marseille
    Marseille, 13003, France
  • CHU Nantes
    Nantes, 44093, France
  • Hôpital Hôtel-Dieu
    Paris, 75004, France
  • Hôpital Lariboisière
    Paris, 75010, France
  • Institut Mutual Montsouris
    Paris, 75014, France
  • Hôpital Necker
    Paris, 75015, France
  • CHI Saint Germain en Laye
    Saint Germain en Laye, 78100, France
  • CH de Saint-Nazaire
    Saint-Nazaire, 44600, France
  • Hôpital Foch
    Suresnes, 92150, France
  • CHU Purpan
    Toulouse, 31059 cedex 9, France
  • Centre Hépato -Biliaire de l'Hôpital Paul Brousse
    Villejuif, 94804, France
07

References and documents

Publications

  • WHO | Sexual health [Internet]. WHO. Available from: http://www.who.int/topics/sexual_health/en/
  • Koole O, Noestlinger C, Colebunders R. Quality of life in HIV clinical trials: why sexual health must not be ignored. PLoS Clin Trials. 2007 Mar 2;2(3):e8. doi: 10.1371/journal.pctr.0020008. No abstract available. PubMed 17332849 ↗
  • Marcellin F, Preau M, Ravaux I, Dellamonica P, Spire B, Carrieri MP. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. HIV Clin Trials. 2007 Sep-Oct;8(5):320-7. doi: 10.1310/hct0805-320. PubMed 17956833 ↗
  • Sandfort TG, Collier KL, Grossberg R. Addressing sexual problems in HIV primary care: experiences from patients. Arch Sex Behav. 2013 Oct;42(7):1357-68. doi: 10.1007/s10508-012-0009-5. Epub 2012 Sep 11. PubMed 22965768 ↗
  • Meystre-Agustoni G, Jeannin A, de Heller K, Pecoud A, Bodenmann P, Dubois-Arber F. Talking about sexuality with the physician: are patients receiving what they wish? Swiss Med Wkly. 2011 Mar 8;141:w13178. doi: 10.4414/smw.2011.13178. eCollection 2011. PubMed 21384286 ↗
  • Dyer K, das Nair R. Why don't healthcare professionals talk about sex? A systematic review of recent qualitative studies conducted in the United kingdom. J Sex Med. 2013 Nov;10(11):2658-70. doi: 10.1111/j.1743-6109.2012.02856.x. Epub 2012 Jul 30. PubMed 22846467 ↗
  • Soykan A, Boztas H, Idilman R, Ozel ET, Tuzun AE, Ozden A, Ozden A, Kumbasar H. Sexual dysfunctions in HCV patients and its correlations with psychological and biological variables. Int J Impot Res. 2005 Mar-Apr;17(2):175-9. doi: 10.1038/sj.ijir.3901267. PubMed 15510190 ↗

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT03468673
Lead sponsor
University Paris 7 - Denis Diderot
Collaborators
University of Sydney, Center of treatment HIV/Aids-São Paulo, Université de Montréal
Responsible party
Dr Martin Duracinsky (Dr, University Paris 7 - Denis Diderot) — Principal investigator
First posted
Mar 16, 2018
Start date
Feb 20, 2015
Primary completion
Dec 31, 2018
Completion
Jun 30, 2020
Last update
Apr 27, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion